Dr. Daniel Gibbs is on a mission to change attitudes on Alzheimer's after 13 years living with the disease himself.
Here's the important reason why...
There may soon be a new tool available to help doctors more firmly diagnose Alzheimer’s disease, according to the results of a study published recently in JAMA Neurology and conducted in part at the Memory and Aging Program at Butler Hospital.
Alzheimer’s disease has three stages: early (mild), middle (moderate), and late (severe). Here is what to expect and what to do during each of them.
Welcome to the blog of the Memory and Aging Program (MAP) at Butler Hospital. We are a world leader in Alzheimer’s research and a local Rhode Island partner in the fight against Alzheimer’s disease and dementia. To learn more about our research and how to get involved, visit butler.org/memory.
Heroes & Pioneers
How this neuropsychologist has come full circle and full-steam ahead in his career and his quest to help end Alzheimer’s at the Memory and Aging Program at Butler Hospital.
Research & Program News
New Data for Investigational Drug for Early-Onset Alzheimer’s Illustrates Value of “Failed” Research Studies
Initial results in a clinical trial aimed at early-onset Alzheimer’s didn’t look promising – but upon further review, the data has spurred further study.
Watch this Alzheimer’s educational video to learn about prevention, symptoms, treatment, resources and research from a panel of Rhode Island experts.
Join the Alzheimer's Prevention Registry
If you’re aged 40 to 85 and are an individual with normal memory, some memory decline, or mild dementia, you can help in the development of breakthrough tests and treatments for Alzheimer’s. Take just a few moments to enroll in our Alzheimer’s Prevention Registry, a tool that allows us to match up individuals interested in participating in research with studies for which they may qualify – either now or in the future.